Joshua Mervis, MD
Dermatology · Boston, MANPI 1306305305
Payments from drug & device makers
Across 192 payments — averaging $87.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$6K
- UCB, Inc.$2K
- Merck$2K
- AbbVie$1K
- Sun Pharmaceutical Industries Inc.$855
- Boehringer Ingelheim International GmbH$625
- plus $4K from 24 others
What the payments were for
- Consulting fees$7,22543%
- Travel & lodging$1,1087%
- Food & beverage$8,31349%
- Education$2491%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 9 | $6,387 |
| UCB, Inc. | 50 | $1,653 |
| Merck | 2 | $1,500 |
| AbbVie(2 entities) | 36 | $1,452 |
| Sun Pharmaceutical Industries Inc. | 7 | $855 |
| Boehringer Ingelheim International GmbH | 1 | $625 |
| Johnson & Johnson(2 entities) | 10 | $454 |
| Galderma Laboratories, L.p. | 5 | $442 |
| E.r. Squibb & Sons, L.L.C. | 13 | $331 |
| Dermavant Sciences, Inc. | 3 | $324 |
| Sanofi | 7 | $318 |
| Novartis | 6 | $280 |
| Lilly USA, LLC | 6 | $266 |
| Chiesi USA, Inc. | 2 | $250 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $236 |
| Avita Medical Americas, LLC | 3 | $208 |
| Regeneron Healthcare Solutions, Inc. | 4 | $179 |
| Pfizer | 5 | $176 |
| Organogenesis Inc. | 1 | $161 |
| VYNE Pharmaceuticals Inc. | 1 | $149 |
| Incyte Corporation | 1 | $127 |
| Mallinckrodt Hospital Products Inc. | 1 | $125 |
| Aroa Biosurgery Incorporated | 4 | $96 |
| Mimedx Group, Inc. | 1 | $86 |
| Smith+Nephew | 4 | $73 |
| Organon | 2 | $60 |
| Integra Lifesciences Corporation | 1 | $24 |
| Krystal Biotech Inc | 1 | $23 |
| Acera Surgical, Inc. | 1 | $22 |
| Molnlycke Health Care US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,895 in reported general payments places this provider in the 85th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 35 | $8,099 |
| Ketoconazole | 135 | $4,707 |
| Clobetasol Propionate | 57 | $2,194 |
| Ciclopirox | 32 | $1,874 |
| Triamcinolone Acetonide | 90 | $912 |
| Mometasone Furoate | 13 | $286 |
| Nystatin | 14 | $178 |
| Clindamycin Phosphate | 13 | $178 |
| Hydrocortisone | 35 | $160 |
| Mupirocin | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Boston
- Alexandra KimballBoston$3.7M
- Gideon SmithBoston$2.6M
- Tarannum JaleelBoston$1.3M
- Maria Beatrice AloraBoston$1.3M
- Martina PorterBoston$1.1M
- Arash MostaghimiBoston$1M
- Emmy GraberBoston$882K
- Ruth Ann VleugelsBoston$786K
- Maryanne SennaBoston$783K
- Gabriela CobosBoston$558K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.